TUESDAY, July 20, 2021 (HealthDay News) — Could cholesterol-lowering statins assist decrease your danger of dying from COVID-19?
For sufferers with a historical past of high blood pressure or heart disease, the reply seems to be sure. At least that is the conclusion of a brand new research that enlisted roughly 10,500 sufferers throughout 104 U.S. hospitals between January and September of 2020.
All had been admitted with a severe bout of COVID-19. Prior to hospitalization, 42% had been taking statins to rein in high cholesterol, with 7% taking statins alone and 35% taking each statins and blood pressure medications.
In the tip, a few fifth of the sufferers both succumbed to COVID-19 or have been discharged to a hospice setting.
“[But] we found that patients taking statin medications prior to getting hospitalized due to COVID-19 had a 41% lower risk of dying during that hospitalization, even after adjusting for other factors like age, gender, other medical problems, and what type of medical insurance they had,” stated research writer Dr. Lori Daniels.
After analyzing information amassed by the American Heart Association, the crew additionally concluded that statin use was equally linked to a 25% decrease danger for growing a “severe outcome” on account of COVID-19 an infection.
Why? Statins might need this impact by “stabilizing the underlying heart conditions for which they are prescribed, making patients more likely to recover from COVID-19,” stated Daniels, director of the cardiovascular intensive care unit on the University of California, San Diego.
But not all sufferers on statins have superior coronary heart illness, Daniels’ crew famous. Many comparatively wholesome sufferers additionally take them in proactively to stave off cardiovascular hassle.
Which begs the query, might statins additionally decrease dying amongst COVID sufferers who do not but have severe underlying heart points? Daniels prompt the jury remains to be out on that query.
She famous that statins pack a probably useful anti-inflammatory punch. Her crew discovered that statins drove dying danger down by 16% amongst sufferers with no prior historical past of coronary heart illness.
Still, Daniels cautioned that for coronary heart wholesome sufferers, the trial outcomes have been “not statistically significant.” And “the present study cannot tell us whether giving patients statins, if they are not already on them, would be helpful,” she confused.